AUROBINDO PHARMA LTD FDA Approval ANDA 209201

ANDA 209201

AUROBINDO PHARMA LTD

FDA Drug Application

Application #209201

Application Sponsors

ANDA 209201AUROBINDO PHARMA LTD

Marketing Status

Prescription001
Prescription002

Application Products

001FOR SUSPENSION;ORALEQ 100MG BASE/5ML0AZITHROMYCINAZITHROMYCIN
002FOR SUSPENSION;ORALEQ 200MG BASE/5ML0AZITHROMYCINAZITHROMYCIN

FDA Submissions

UNKNOWN; ORIG1AP2018-10-09STANDARD
LABELING; LabelingSUPPL2AP2020-01-23STANDARD
LABELING; LabelingSUPPL3AP2020-10-18STANDARD
LABELING; LabelingSUPPL4AP2022-01-12STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null7
SUPPL3Null15
SUPPL4Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209201
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZITHROMYCIN","activeIngredients":"AZITHROMYCIN","strength":"EQ 100MG BASE\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"AZITHROMYCIN","activeIngredients":"AZITHROMYCIN","strength":"EQ 200MG BASE\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/09\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"01\/23\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-01-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.